Home › Trial NCT01600053
Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia
- Trial IDNCT01600053
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorThomas Kipps
- Enrollment11
- Start date2011-11
- ConditionsChronic Lymphocytic Leukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.